Fourier Intelligence, a neurorehabilitation robotics firm, recently raised more than USD 62 million in Series D funding. The funds will be used to boost Fourier’s go-to-market development and expansion, according to the Shanghai-based start-up. Fourier also intends to expand its healthcare robot solutions’ innovation.
Fourier provides a variety of rehabilitation robots for upper and lower limbs, as well as movement and balance. RehabHub, a smart healthcare robotic technology, is also operated by the company. With a uniform user account provided by the platform, RehabHub is proven to monitor patients’ progress.All of Fourier’s Motus devices can connect to RehabHub, providing patients with a complete rehabilitation experience.
Despite the hurdles faced by the global outbreak, Fourier Intelligence founder and Group CEO Alex Gu noted, “The rehabilitation business has huge tech adoption potential, and we demonstrated over 3x growth in revenue in 2021.” “With an aging population, an increase in the number of patients with chronic conditions, and the development of rehabilitation services in clinics, China is seeing an increase in demand for rehabilitation services.” There has always been a physician shortage in the United States.”
As China’s population ages, there is a growing demand for rehabilitation services, said Joanne Xu, a partner at SoftBank Investment Advisers. However, these patients face a dearth of trained therapists. “We believe Fourier Intelligence is ideally positioned to address this skill shortage by utilizing technology to deliver effective and quantified treatments that improve patient outcomes.”
In conjunction with more than 30 world-leading hospitals and research organizations, it has developed an integrated solution that combines a digital platform, hospital services, and a broad product line.
We’re looking forward to working with Alex Gu and the rest of the team to encourage technological innovation in China’s rehabilitation industry.
The global robot as a service market was valued at roughly USD 14.5 billion in 2021 and is expected to reach USD 44 billion by 2028 at a CAGR of 16.5% during the forecast period 2022-2028.